Purchase Order HHSN268201300130P

This is a firm-fixed-price purchase order awarded by the Department of Health and Human Services Food and Drug Administration to Fujifilm Cellular Dynamics, Inc., a foreign-owned, for-profit manufacturer of human induced pluripotent stem cell-derived cells. The $26,680 contract is to provide specialized cell cultures, including cardiomyocytes, neurons, astrocytes, and hepatocytes, to support the FDA's active research program. The award has no set-aside designation and is a sole-source award,...

The National Institute of Child Health and Human Development (NICHD) awarded Genscript USA Inc. a $24,000 firm fixed-price call order under a blanket purchase agreement (BPA) for RAD knockout HEK293T cell lines. The contract was awarded on June 24, 2015, with an ultimate completion date of June 23, 2016, and performed at the NICHD's facility in Bethesda, Maryland. This procurement was not designated as a set-aside contract. Genscript USA Inc., a Piscataway, New Jersey-based biotechnology company...

The U.S. Food and Drug Administration (FDA), through its National Center for Toxicological Research (NCTR), awarded a $24,895.00 firm-fixed-price purchase order to Fujifilm Cellular Dynamics, Inc. for the supply of Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes (hiPSC-CMs), also referred to as "iCell Macrophages" from lot #106775. This sole-source procurement was conducted under the authority of FAR 13.106-1(b)(1) to support an approved scientific study (S00913) focused...

This contract award to Fujifilm Cellular Dynamics, Inc. (FCDI) is for the provision of human induced pluripotent stem cell-derived cardiomyocytes (hiPSC-CMs) to the Food and Drug Administration (FDA). The $42,995 firm-fixed-price purchase order has a period of performance through December 31, 2024. FCDI is a foreign-owned, for-profit manufacturer of specialized human cell cultures, particularly those derived from induced pluripotent stem cells (iPSCs). The company has an extensive history of...

This federal contract award with ID 75N90019P00629 was issued by the National Institutes of Health (NIH) Clinical Center to Cell Line Genetics, Inc. for $11,200.00. The contract is for a firm fixed-price purchase order with a performance period ending on June 30, 2020. The contract was not set aside for any special type of business. Cell Line Genetics, Inc. is a for-profit organization that is minority-owned, woman-owned, and Hispanic American-owned. This award appears to be related to a...

This purchase order awarded to Rutgers, The State University on March 3, 2009, provides 20 human lymphoblast cell lines required for an ongoing pharmacogenetic research project conducted collaboratively between the university's Biomarker Lab and Dr. Francis McMahon's Genetic Lab. The award, valued at $4,000 firm fixed price, was made to Rutgers as a sole source supplier, indicating the university possesses unique capabilities to provide these specialized biological materials. The contract was...

The National Institutes of Health's National Human Genome Research Institute awarded a $20,000 firm fixed price purchase order to Alstem, Inc. of San Pablo, California. Under the terms of the contract, Alstem will provide induced pluripotent stem cell generation from human fibroblasts using an episomal method. The work will be conducted at Alstem's place of performance in San Pablo and will be completed by December 31, 2023. No major subcontractors or set aside designations were identified....

The Food and Drug Administration (FDA) awarded a purchase order to Genscript USA Inc. on July 12, 2019, for the development of a stable cell line expressing target antibody 41, with a ceiling value of $20,285.30. This firm fixed-price contract, which concluded on December 31, 2019, represents a focused procurement for specialized biotechnology services to support the FDA's research and development initiatives. The work was performed at Genscript's facility in Piscataway, New Jersey, where the...

This firm-fixed-price purchase order was awarded by the Food and Drug Administration (FDA), a civilian agency within the Department of Health and Human Services (HHS), to Fujifilm Cellular Dynamics, Inc., a foreign-owned, for-profit manufacturer of induced pluripotent stem cell-derived human cell lines. The $79,500.00 contract is for the supply of iCell Cardiomyocytes, a specialized cell product used in biomedical research and drug development. This contract is not set aside for small...

The Department of Health and Human Services Centers for Disease Control and Prevention awarded a $231,000.00 firm-fixed-price purchase order to Life Technologies Corporation, a for-profit manufacturer, for the provision of EXPI293F license and cell lines. This contract does not have a set-aside designation. The products and services are to be delivered by the July 31, 2021 completion date. Life Technologies Corporation is a subsidiary of the parent company Thermo Electron Corporation, which...